Chronic News and Research

RSS

Thinning of right hemisphere in brain a marker for familial form of depression

Findings from one of the largest-ever imaging studies of depression indicate that a structural difference in the brain - a thinning of the right hemisphere - appears to be linked to a higher risk for depression, according to new research at Columbia University Medical Center and the New York State Psychiatric Institute.

23 Mar 2009

On demand doctor's appointments do not improve diabetes care

Same-day medical scheduling, also known as on demand scheduling, does not improve care of chronically ill individuals, according to a study of 4,060 adult patients with diabetes.

23 Mar 2009

Garden peas may help fight high blood pressure, kidney disease

Researchers in Canada are reporting that proteins found in a common garden pea show promise as a natural food additive or new dietary supplement for fighting high blood pressure and chronic kidney disease (CKD).

22 Mar 2009

Research suggests those who have chronic pain may need to assess vitamin D status

Mayo Clinic research shows a correlation between inadequate vitamin D levels and the amount of narcotic medication taken by patients who have chronic pain

22 Mar 2009

FDA warning on oysters recently harvested from Mississippi area 2C

The U.S. Food and Drug Administration is advising retailers and food service operators not to offer for sale oysters harvested between Feb. 24 and March 17, 2009, from Mississippi Area 2C, located in the Mississippi Sound portion of the Gulf of Mexico near Pass Christian, Miss. Further, consumers are advised not to eat such oysters.

22 Mar 2009

Severe vomiting case due to chronic marijuana use

This obscure clinical manifestation of severe vomiting sickness due to chronic abuse of marijuana, recognized by Dr. Sontineni and his colleagues at the Creighton University of Omaha, NE, was published on March 14, 2009 World Journal of Gastroenterology.

22 Mar 2009

Researchers investigate new way to block reproduction of the hepatitis C virus

Massachusetts General Hospital (MGH) researchers are investigating a new way to block reproduction of the hepatitis C virus (HCV) - targeting not the virus itself but the human genes the virus exploits in its life cycle.

20 Mar 2009

Novel stimulation method sparks hope for Parkinson's disease sufferers

A novel stimulation method, the first potential therapy to target the spinal cord instead of the brain, may offer an effective and less invasive approach for Parkinson's disease treatment, according to pre-clinical data published in the journal Science by researchers at Duke University Medical Center.

20 Mar 2009

Research could lead to potential new drugs for treating asthma

The American Asthma Foundation announced that a significant research discovery they funded has been licensed by a leading biotech company.

20 Mar 2009

Study looks at maggot therapy on wound healing

Larval (maggot) therapy has similar health benefits and costs compared with a standard treatment for leg ulcers, find two studies published on bmj.com.

20 Mar 2009

First time portable CT used for skull base endoscopic transnasal surgery

When Susan Dailey was 11 years old, she was admitted to a hospital by her loving parents, who assumed she would get a routine tonsillectomy to cure her chronic sore throat.

20 Mar 2009

Factors associated with proteinuria identified

Characteristics associated with proteinuria - a predictor of decline in child kidney function - have been identified, according to a study appearing in the March 2009 issue of the Clinical Journal of the American Society Nephrology (CJASN).

20 Mar 2009

Barriers to diabetes care include restaurants and high-risk lifestyles

Eating out, lack of social support and high-risk lifestyles are just some of the barriers that stop patients with type 2 diabetes from controlling their condition, according to a research review that covered 8,900 patients and 4,550 healthcare providers from 28 countries.

20 Mar 2009

Understanding mental illness through gene-environment interactions

Biological Psychiatry, published by Elsevier, is very pleased to present a special section of its February 1st issue devoted to fundamental new insights into epigenetics, a field of research devoted to understanding how the environment can produce long-lasting or even heritable changes in gene function without altering the DNA sequence.

17 Mar 2009

HPV vaccine may prevent preterm births

Chronic human papilloma virus (HPV)-infections can lead to cellular changes in the cervix that can be a pre-stage to cervical cancer.

17 Mar 2009

Hearing could hold key to unlocking schizophrenia mystery

Measuring brain waves in response to hearing a variety of tones appears to be a useful way to begin understanding the underlying genetic abnormalities associated with schizophrenia, says a study headed by researchers at Harvard-affiliated McLean Hospital.

17 Mar 2009

No clear link between the levels of vitamin D in the blood and depression

A lack of Vitamin D, due to reduced sunlight, has been linked to depression and the symptoms of Seasonal Affective Disorder (SAD), but research by the University of Warwick shows there is no clear link between the levels of vitamin D in the blood and depression.

17 Mar 2009

Discovery of new mechanism for the processing of endocannabinoids

New research funded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, has identified a new mechanism for the processing of endocannabinoids, natural brain compounds similar to THC, the active ingredient in marijuana.

17 Mar 2009

Budesonide nasal wash shows promise for chronic rhinosinusitis

A nasal wash containing the corticosteroid budesonide appears to reduce symptoms of chronic rhinosinusitis without suppressing the function of the adrenal glands, a known complication of this type of drug that would indicate absorption throughout the whole body, according to a report in the March issue of Archives of Otolaryngology-Head & Neck Surgery.

16 Mar 2009

Sirion Therapeutics sNDA for Durezol to treat uveitis accepted for FDA review

Sirion Therapeutics, Inc. announced today that its supplemental New Drug Application (sNDA) submitted to the U.S. Food and Drug Administration (FDA) seeking market approval of Durezol(TM) (difluprednate ophthalmic emulsion) 0.05% to treat endogenous anterior uveitis has been accepted for review.

16 Mar 2009